Описание: Hiding Politics in Plain Sight examines the costs of market mechanisms, especially cause marketing as a strategy for change. Industry and corporate-connected individuals use market mechanisms to brand issues like breast cancer widely, shaping public understanding. But framed as consensus-based social issues rather than contentious political issues, they essentially hide politics in plain sight.
Автор: Piccart Название: Breast Cancer Management and Molecular Medicine ISBN: 3540282653 ISBN-13(EAN): 9783540282655 Издательство: Springer Рейтинг: Цена: 48913.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: Provides an overview of the techniques, agents and approaches for breast cancer and its treatment. This book presents organ-specific approaches and their impact on the re-classification of breast cancer. It also addresses the integration of biological markers, technologies, diagnostic and therapeutic approaches into clinical trials and practice.
Автор: Hunt Название: Breast Cancer ISBN: 0387349502 ISBN-13(EAN): 9780387349503 Издательство: Springer Рейтинг: Цена: 13974.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: Now in this, its second edition, this fully revised clinical guidebook is an essential resource for the practitioner, allowing quick, authoritative access to the latest and best in multimodality therapies.
Автор: Morrow Название: Managing Breast Cancer Risk.2003 ISBN: 155009260X ISBN-13(EAN): 9781550092608 Издательство: McGraw-Hill Рейтинг: Цена: 5670.00 р. Наличие на складе: Поставка под заказ.
Описание: Managing Breast Cancer Risk is a single source for information needed by primary care physicians, nurses, gynecologists, as well as oncologic specialists who deal with women who are concerned about breast cancer. Its purpose is to bring together a multidisciplinary group of experts to address breast cancer risk in a clinically meaningful way. Chapters providing detailed information on individual risk factors are accompanied by a discussion of models, which integrate multiple factors for a more complete assessment of risk. Traditional strategies for risk management, including surveillance and prophylactic surgery, are reviewed, and the data on newer techniques such as ductal lavage and screening with magnetic resonance is presented. The rational for chemoprevention with selective estrogen receptor modulators (SERMS) is discussed, and the evidence for tamoxifen as a chemopreventative is updated. The potential for chemoprevention with newer SERMS and the aromatase inhibitors is reviewed. Finally, the critical (and often ignored) areas of quality of life and symptom management are addressed.
ООО "Логосфера " Тел:+7(495) 980-12-10 www.logobook.ru
